Stent thrombosis in patients treated with thienopyridines: clinical description of 10 cases

References

• Barbato E, Marco J, Wijns W. Direct stenting. Eur Heart J 2003; 24: 394–403.
   Google Scholar
• Bartorelli AL, Trabattoni D. Contemporary antithrombotic strategies in patients undergoing coronary stent implantation. Minerva Cardioangiol 2002; 50: 517–30.
   Google Scholar
• Batchelor WB, Mahaffey KW, Berger PB et al. the ATLAST Trial Investigators. A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol 2001; 38: 1608–13.
   PubMed Web of Science ®Google Scholar
• Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, Investigators FT. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000; 102: 624–9.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Bertrand ME, Berger PB et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002; 39: 9–14.
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Bairn DS, Ho KK et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967–71.
   PubMed Web of Science ®Google Scholar
• Hall P, Nakamura S, Maiello L et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996; 93: 215–22.
   PubMed Web of Science ®Google Scholar
• King III SB. Optimizing antiplatelet therapy in coronary interventions. Clin Cardiol 2000; 23(VI): VI-8-13.
   Google Scholar
• Laarman G, Muthusamy TS, Swart H et al. Direct coronary stent implantation: safety, feasibility, and predictors of success of the strategy of direct coronary stent implantation. Catheter Cardiovasc Interv 2001; 52: 443–8.
   PubMedGoogle Scholar
• Lau WC, Waskell LA, Watkins PB et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 2003; 107: 32–7.
   PubMed Web of Science ®Google Scholar
• Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: Evolving issues and current concepts. J Am Coll Cardiol 27: 494–5031996.
   Google Scholar
• Mehta SR, Yusuf S, Peters RJ et al. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527–33.
   PubMed Web of Science ®Google Scholar
• Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997; 29: 6–12.
   PubMed Web of Science ®Google Scholar
• Moussa I, Oetgen M, Roubin G et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999; 99: 2364–6.
   PubMed Web of Science ®Google Scholar
• Nath FC, Muller DW, Ellis SG et al. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 1993; 21: 622–7.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Rinaldi MJ, Pinto DS, Cohen DJ. Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol 2002; 14: 364–8.
   Google Scholar
• Savage MP, Fischman DL, Schatz RA et al. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1994; 24: 1207–12.
   PubMed Web of Science ®Google Scholar
• Schuhlen H, Kastrati A, Pache J, Dirschinger J, Schomig A. Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a fourweek ticlopidine regimen. J Am Coll Cardiol 2001; 37: 2066–73.
   PubMed Web of Science ®Google Scholar
• Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489–95.
   PubMed Web of Science ®Google Scholar
• Steinhubl SR, Berger PB, Mann JT 3rd, et al. CREDO investigators. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatlet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411–20.
   Google Scholar
• Leon MB, Bairn DS, Popma JJ et al. A clinical trial comparing three antithrombotic-drug regimens after coronaryartery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665–71.
   PubMed Web of Science ®Google Scholar